RANDOMIZED CONTROLLED STUDY COMPARING ORAL MISOPROSTOL WITH INTRAMUSCULAR OXYTOCIN IN ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202211835951582

Enrollment

271

Registered

2022-11-02

Start date

2017-10-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active management of third stage of labour

Interventions

Oxytocin group

Misoprostol group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: No known risk factor for postpartum hemorrhage Booked parturient Gestational age of 37 to 40 weeks

Exclusion criteria

Exclusion criteria: Those with haemoglobin concentration = 10gm/dl. Haemoglobinopathies in pregnancy Chronic medical illnesses such as cardiac disease, Hypertensive disease and asthma in pregnancy Hyperthermia of > 37.2?C Those that did not consent

Design outcomes

Primary

Measure	Time frame
Blood loss after delivery and proportion of participants with PPH (>500ml)	—

Secondary

Measure	Time frame
The secondary outcome measures were duration of third stage of labour, changes in maternal haemoglobin concentration , need for the use of additional oxytocic and the occurrences of adverse effects such as nausea, vomiting, diarrhoea, shivering and rise in temperature and retained placenta.	—

Countries

Nigeria

Contacts

Public ContactAbdulrasaq Sambo

Obstetrician and Gynecologist

sarasaq@yahoo.com+2348052336310

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026